Ecully, February 7, 2023 NET SALES AS OF DECEMBER 31, 2022 PCAS (Euronext Paris: PCA), a specialist in developing and producing complex molecules for life sciences and innovative technologies, has announced the publication of its consolidated net sales as of December 31, 2022. The PCAS Group has generated consolidated net sales of €226.4 million as of December 31, 2022, a 21.1% increase compared to the same period during the previous financial year (+17.9% at a constant exchange rate). In millio
Ecully, December 21, 2022 The PCAS Board of Directors met on December 20, 2022. During this meeting, the Board of Directors focused on the difficulties encountered in the development of financial and commercial relations with a major client of the Group. PCAS is facing significant delays in the payment by this client of invoices corresponding to work carried out and delivered. Due to these unjustified late payments which correspond to very significant amounts and the impossibility as of today to
+ Ecully, November 28, 2022 APPOINTMENT OF A NEW CHAIRMAN At its meeting of November 28, 2022, the PCAS Board of Directors formally acknowledged the resignation of Mr. Philippe Clavel as Chief Executive Officer of PCAS. The Board of Directors thanked Mr. Philippe Clavel for his collaboration with PCAS Group. Consequently, the Board of Directors decided to appoint Mr. Jean-Louis Martin as Chief Executive Officer of PCAS. Mr. Jean-Louis Martin, currently Vice President Human Resources and Industri